The World Health Organization (WHO) has recently announced the Health Technology Access Pool (HTAP). This serves as a successor to the COVID-19 Technology Access Pool (C-TAP). This initiative marks a significant step towards more equitable access to a broad range of health products. The aim is to enhance global health security.
Launched in May 2020, C-TAP was a collaborative effort between WHO, the Government of Costa Rica, and other partners. This platform was instrumental in providing a forum for technology partners to share intellectual property, knowledge, and data voluntarily. Despite the challenges of establishing a novel mechanism amidst a pandemic, C-TAP managed to secure six transparent, non-exclusive global licences involving 15 technologies that span research and development (R&D) tools, diagnostics, and vaccines.
HTAP is built on the foundation laid by C-TAP but incorporates structural, process, and other changes to attract and support a diverse range of priority technologies more effectively. It aims to promote access to health products that respond to public health priorities, including pandemic preparedness, and are relevant during and outside health emergencies.
HTAP investments will amplify the public health value and increase the attractiveness of licensed technologies to recipient manufacturers. This approach will realise greater market opportunities and financial sustainability. The announcement on the licensing of a rapid diagnostic test platform technology serves as an example of such an approach.
In the first quarter of 2024, WHO will publish further details on how HTAP will operate and the technologies it will target. Plans are in place to officially launch HTAP in the second quarter of 2024. In the interim, WHO will adopt the principles and approach described above in evaluating opportunities to secure health technologies and expand regional or global production capacity.
Gain insight into the U.S. cancer control agenda through a clear analysis of President Trump’s 2025 proclamation.
This article outlines key messages, national priorities, and implications for public health strategy—valuable for policymakers, healthcare leaders, and life sciences executives.
#SyenzaNews #oncology #HealthEconomics #healthcarepolicy
Did you know that tobacco is a leading cause of head and neck cancer?
A recent study unravels the complex mutational landscape influenced by tobacco smoke, revealing new insights into how tobacco and alcohol work together to amplify DNA damage. These findings not only highlight the need for tailored prevention strategies but also pave the way for targeted therapeutic interventions.
Jump into the details and discover the implications for public health initiatives and policy!
#SyenzaNews #oncology #healthcare #HealthEconomics
How can innovative models transform diabetes care in South Africa?
Discover how Discovery Health’s shared-value program is not only improving patient outcomes through enhanced glycemic control, but also reducing healthcare costs. This strategic approach is making significant strides in diabetes management, setting a precedent for future healthcare innovations.
Curious to learn more? Dive into the full article for an in-depth look at the program’s impact!
#SyenzaNews #HealthcareInnovation #HealthEconomics #DigitalTransformation
SPEAK WITH US
CORRESPONDENCE ADDRESS
1950 W. Corporate Way, Suite 95478
Anaheim, CA 92801, USA
WRITE US
JOIN NEWSLETTER
